Skip to main content
Tanvex BioPharma, Inc. (TPE:6541)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.10
+0.05 (0.18%)
Nov 13, 2026, 1:30 PM CST

Tanvex BioPharma Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
691.06400.9734.6861.4122.45.41
Revenue Growth
207.37%1056.27%-43.53%174.11%314.43%1702.00%
Gross Profit
-976.95-440.718.2959.7-19.353.55
Operating Income
-1,501-1,388-1,357-2,101-1,606-1,599
Net Income
-1,592-1,500-1,382-2,137-1,641-1,543
Earnings Per Share
-6.01-6.13-8.90-16.58-13.95-14.21
EPS Growth
------

Revenue by Geography
Chart
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Taiwan
170.03-53.722.45.41
United States
230.9434.687.71--
Total
400.9734.6861.4122.45.41

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
602.71878.71376.96380.75786.232,223
Total Debt
2,3291,5781,6481,7321,8391,759
Net Cash (Debt)
-1,727-699.69-1,271-1,351-1,053463.95
Net Cash Growth
------15.52%
Net Cash Per Share
-6.52-2.86-8.19-10.48-8.954.27

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-970.25-1,005-1,151-1,435-1,334-1,387
Capital Expenditures
-706.84-668.26-105.91-71.02-93.5-29.82
Free Cash Flow
-1,677-1,674-1,257-1,506-1,427-1,417
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-141.37%-109.91%23.91%97.21%-86.36%65.67%
Operating Margin
-217.14%-346.21%-3912.40%-3420.80%-7166.21%-29581.65%
Pretax Margin
-231.20%-374.89%-3982.94%-3479.30%-7325.06%-28545.86%
Profit Margin
-230.36%-374.13%-3983.94%-3480.00%-7325.16%-28546.26%
FCF Margin
-242.68%-417.41%-3623.36%-2452.94%-6370.97%-26208.75%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
10.7836.32308.48141.91552.433787.62